Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes
出版年份 2023 全文链接
标题
Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes
作者
关键词
-
出版物
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-02
DOI
10.1007/s10557-023-07517-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy
- (2023) Wei Li et al. eLife
- WCN23-0761 SGLT2 INHIBITOR TREATMENT MAY ENHANCE KIDNEY OXYGENATION AND ATTENUATE HIF1A EXPRESSION IN YOUNG PERSONS WITH TYPE 2 DIABETES
- (2023) V. Nair MS et al. Kidney International Reports
- Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway
- (2022) Juliana Cordovil Cotrin et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
- (2022) Huitzilihuitl Saucedo-Orozco et al. Journal of Lipid and Atherosclerosis
- Direct cardiac effects of SGLT2 inhibitors
- (2022) Sha Chen et al. Cardiovascular Diabetology
- Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis
- (2022) Amal F. Dawood et al. Biomedicines
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- (2022) Zofia Wicik et al. Frontiers in Pharmacology
- Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
- (2022) Silvio E Inzucchi et al. Lancet Diabetes & Endocrinology
- High Glucose Induced Smad3 Linker Phosphorylation and CCN2 Expression is Inhibited by Dapagliflozin in a Diabetic Tubule Epithelial Cell Model
- (2021) Xinlu Pan et al. BIOSCIENCE REPORTS
- Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice
- (2021) Li Dong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activation of HIF1α Rescues the Hypoxic Response and Reverses Metabolic Dysfunction in the Diabetic Heart
- (2021) Maria da Luz Sousa Fialho et al. DIABETES
- SGLT2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body‐induced NRF2 activation
- (2021) Mi Na Kim et al. DIABETES OBESITY & METABOLISM
- Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
- (2021) Nikole J. Byrne et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2‐knockout mice
- (2021) Shan Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study
- (2021) Diana Nabrdalik-Leśniak et al. Oxidative Medicine and Cellular Longevity
- Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
- (2021) Dominique Croteau et al. Journal of the American Heart Association
- Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus
- (2021) Wenxin Sha et al. Journal of Diabetes Research
- Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
- (2021) Yinhui Wang et al. Frontiers in Pharmacology
- The effects of exercise training on cardiac matrix metalloproteinases activity and cardiac function in mice with diabetic cardiomyopathy
- (2021) Eleni Dede et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- N-Acetyl Cysteine, Selenium, and Ascorbic Acid Rescue Diabetic Cardiac Hypertrophy via Mitochondrial-Associated Redox Regulators
- (2021) Iram Mushtaq et al. MOLECULES
- Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
- (2021) Ning Zhu et al. Journal of Diabetes Research
- Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy
- (2021) Wenyi Wu et al. Frontiers in Medicine
- Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
- (2020) M. Arow et al. Cardiovascular Diabetology
- Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat
- (2020) Sin-Hee Park et al. Cardiovascular Diabetology
- Dapagliflozin Suppresses Hepcidin And Increases Erythropoiesis
- (2020) Husam Ghanim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3
- (2020) Chang-ling Li et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
- (2020) Huan Chen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Dapagliflozin, a sodium glucose cotransporter 2 inhibitors, protects cardiovascular function in type-2 diabetic murine model
- (2020) Sohair Saleh et al. JOURNAL OF GENETICS
- Mechanisms Leading to Differential Hypoxia Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics
- (2020) Milton Packer AMERICAN JOURNAL OF KIDNEY DISEASES
- Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
- (2020) Thiquynhnga Nguyen et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
- (2020) Laween Uthman et al. CARDIOVASCULAR DRUGS AND THERAPY
- Growth arrest‐specific 6 modulates adiponectin expression and insulin resistance in adipose tissue
- (2020) Sheng‐Chiang Su et al. Journal of Diabetes Investigation
- ROS- and HIF1α-dependent IGFBP3 upregulation blocks IGF1 survival signaling and thereby mediates high-glucose-induced cardiomyocyte apoptosis
- (2019) Yao-Te Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Is the placental proteome impaired in well-controlled gestational diabetes?
- (2019) Silvia Burlina et al. JOURNAL OF MASS SPECTROMETRY
- Overexpression of Axl reverses endothelial cells dysfunction in high glucose and hypoxia
- (2019) Zuo Pei-Yuan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Activator protein-1 and caspase 8 mediate p38α MAPK-dependent cardiomyocyte apoptosis induced by palmitic acid
- (2019) Charles C. Oh et al. APOPTOSIS
- Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload
- (2019) Lin Shi et al. AMERICAN JOURNAL OF HYPERTENSION
- Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart
- (2019) Wei Ding et al. Frontiers in Endocrinology
- Abstract P190: Transcriptomic Data Analysis Reveals Sex-Related Differences in the Interplay Between Toll-Like Receptor 4 and Heat-Shock Protein 70 in the Aorta of Type 2 Diabetic Donors
- (2019) Amanda Almeida De Oliveira et al. HYPERTENSION
- Effects of empagliflozin on nondiabetic salt-sensitive hypertension in uninephrectomized rats
- (2019) Sua Kim et al. HYPERTENSION RESEARCH
- Long-term moderate intensity exercise alleviates myocardial fibrosis in type 2 diabetic rats via inhibitions of oxidative stress and TGF-β1/Smad pathway
- (2019) Shi-Qiang Wang et al. Journal of Physiological Sciences
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of microRNA‐150‐5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose‐treated cardiac fibroblasts
- (2019) Hui Che et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
- (2019) Ryoichi Bessho et al. Scientific Reports
- Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF‑κB/c‑fos signaling pathway
- (2019) Min Wang et al. Experimental and Therapeutic Medicine
- Neuregulin-1 Promotes Myocardial Angiogenesis in the Rat Model of Diabetic Cardiomyopathy
- (2018) Chun Gui et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts
- (2018) Liping Meng et al. Molecular Medicine Reports
- Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy
- (2018) Vajir Malek et al. CARDIOVASCULAR RESEARCH
- RNA-seq analyses the effect of high-salt diet in hypertension
- (2018) Huifeng Xu et al. GENE
- A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn2+-transporters in cardiomyocytes from insulin-resistant metabolic syndrome rats through inhibition of oxidative stress
- (2018) Yusuf Olgar et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.
- (2018) Hiroto Oshima et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrine suppresses cardiac fibrosis by inhibiting the TGF‑β/Smad pathway in experimental diabetic cardiomyopathy
- (2017) Yong Zhang et al. Molecular Medicine Reports
- ATF5 regulates β-cell survival during stress
- (2017) Christine A. Juliana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unifying mechanism for different fibrotic diseases
- (2017) Gerlinde Wernig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p53 regulates the cardiac transcriptome
- (2017) Tak W. Mak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling
- (2017) Jinsheng Lai et al. Scientific Reports
- The Transcription Factor ATF5 Mediates a Mammalian Mitochondrial UPR
- (2016) Christopher J. Fiorese et al. CURRENT BIOLOGY
- Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
- (2016) Junlian Gu et al. DIABETES
- PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice
- (2016) Radiosa Gallini et al. EXPERIMENTAL CELL RESEARCH
- miR-30c and miR-181a synergistically modulate p53–p21 pathway in diabetes induced cardiac hypertrophy
- (2016) Satish K. Raut et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Expression Level of mRNA, Protein, and DNA Methylation Status of FOSL2 of Uyghur in XinJiang in Type 2 Diabetes
- (2016) Jun Li et al. Journal of Diabetes Research
- Effects of hydrogen sulfide on myocardial fibrosis in diabetic rats: Changes in matrix metalloproteinases parameters
- (2015) Ting Xiao et al. BIO-MEDICAL MATERIALS AND ENGINEERING
- Study on the mechanism of HIF1a-SOX9 in glucose-induced cardiomyocyte hypertrophy
- (2015) Qianqian Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes
- (2015) Yeyou Liang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy
- (2015) Yanfei Xia et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- An Altered Pattern of Myocardial Histopathological and Molecular Changes Underlies the Different Characteristics of Type-1 and Type-2 Diabetic Cardiac Dysfunction
- (2015) Tamás Radovits et al. Journal of Diabetes Research
- Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy
- (2015) Lalage A. Katunga et al. Molecular Metabolism
- Genetically Low Antioxidant Protection and Risk of Cardiovascular Disease and Heart Failure in Diabetic Subjects
- (2015) Camilla J. Kobylecki et al. EBioMedicine
- Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation
- (2014) Shaoping Zhang et al. Cardiovascular Diabetology
- Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival
- (2014) Danhua Zhang et al. DEVELOPMENTAL BIOLOGY
- Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy
- (2014) Kento Kitada et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
- (2014) S. Ramakrishnan et al. Journal of Neuroimmune Pharmacology
- Significance of AT1 Receptor Independent Activation of Mineralocorticoid Receptor in Murine Diabetic Cardiomyopathy
- (2014) Yuji Nagatomo et al. PLoS One
- Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice
- (2014) Romana Bohuslavova et al. BMC Endocrine Disorders
- Bach1 deficiency protects pancreatic β-cells from oxidative stress injury
- (2013) Keiichi Kondo et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner
- (2013) Bridgette F. Peake et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Reversal of mitochondrial proteomic loss in Type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase
- (2013) Walter A. Baseler et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel–Lindau deficient renal clear cell carcinoma
- (2013) Yao-Hui Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Signal Transduction
- (2013) Jingying Wang et al. CIRCULATION
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart
- (2012) Wanli Xue et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- α11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy
- (2012) Ilana Talior-Volodarsky et al. CARDIOVASCULAR RESEARCH
- Metformin reverses hexokinase and phosphofructokinase downregulation and intracellular distribution in the heart of diabetic mice
- (2012) Daniel Da Silva et al. IUBMB LIFE
- FOSL2 promotes leptin gene expression in human and mouse adipocytes
- (2012) Christiane D. Wrann et al. JOURNAL OF CLINICAL INVESTIGATION
- New insights into adipocyte-specific leptin gene expression
- (2012) Christiane D. Wrann et al. Adipocyte
- Prolyl hydroxylase domain protein 3 targets Pax2 for destruction
- (2011) Bing Yan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
- (2011) Vasundhara Kain et al. Cardiovascular Diabetology
- Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway
- (2009) Min Wang et al. ACTA PHARMACOLOGICA SINICA
- Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy
- (2009) Bing Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats
- (2009) Wang Min et al. Cardiovascular Diabetology
- Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice
- (2009) Pei-chun Chao et al. Nutrition & Metabolism
- Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
- (2008) Sophie Linthout et al. BASIC RESEARCH IN CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More